146 related articles for article (PubMed ID: 16277895)
1. [Study of the prevention of chemotherapy-induced ovarian damage by gonadotropin-releasing hormone agonist in rat model].
Yuan GW; Shen K; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):666-9. PubMed ID: 16277895
[TBL] [Abstract][Full Text] [Related]
2. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of estrogen against chemotherapy-induced ovarian damage in rats].
Han LP; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):872-5. PubMed ID: 19460696
[TBL] [Abstract][Full Text] [Related]
4. [Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model].
Yuan GW; Shen K; Yang JX
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1428-31. PubMed ID: 16029659
[TBL] [Abstract][Full Text] [Related]
5. [Effect of GnRH analogs on the expression of Bcl-2 gene family in the ovary of rats with cyclophosphamide-induced ovarian damage].
Peng P; Yang DZ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2014-7. PubMed ID: 19033116
[TBL] [Abstract][Full Text] [Related]
6. A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats.
Ataya KM; McKanna JA; Weintraub AM; Clark MR; LeMaire WJ
Cancer Res; 1985 Aug; 45(8):3651-6. PubMed ID: 3926307
[TBL] [Abstract][Full Text] [Related]
7. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
Li X; Kang X; Deng Q; Cai J; Wang Z
Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
[TBL] [Abstract][Full Text] [Related]
9. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
Huang YH; Zhao XJ; Zhang QH; Xin XY
Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
[TBL] [Abstract][Full Text] [Related]
10. [Effects of gonadotroph-releasing hormone analogues on follicle apoptosis in rats with chemotherapy-induced ovarian damage].
Peng P; Mo YQ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL; Yang DZ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):106-10. PubMed ID: 20117996
[TBL] [Abstract][Full Text] [Related]
11. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated bcl-2 gene therapy improves function and structure of chemotherapy-damaged ovaries in wistar rats.
Wang X; He Y; Liu M; Fu X
Am J Reprod Immunol; 2013 May; 69(5):518-28. PubMed ID: 23311825
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment.
Gui T; Yuan G; Shen K; Cao D; Yang J; Wu M; Lang J
Onco Targets Ther; 2015; 8():661-7. PubMed ID: 25848306
[TBL] [Abstract][Full Text] [Related]
14. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
[TBL] [Abstract][Full Text] [Related]
15. Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles.
Jarrell J; YoungLai EV; McMahon A; Barr R; O'Connell G; Belbeck L
Cancer Res; 1987 Oct; 47(19):5005-8. PubMed ID: 3113726
[TBL] [Abstract][Full Text] [Related]
16. Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat.
Jarrell J; Lai EV; Barr R; McMahon A; Belbeck L; O'Connell G
Cancer Res; 1987 May; 47(9):2340-3. PubMed ID: 3105875
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
19. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
20. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure.
Letterie GS
Hum Reprod; 2004 Apr; 19(4):831-7. PubMed ID: 15033951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
